Status:
COMPLETED
Enhancing Resilience in Senior Community Residents
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Quality of Life
Stress, Psychological
Eligibility:
All Genders
Phase:
NA
Brief Summary
This randomized waitlist-controlled trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP), a mind-body intervention, to enhance r...
Detailed Description
This randomized control trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP) to improve resilience and flourishing among older a...
Eligibility Criteria
Inclusion
- Resident of an Erickson Senior Living community
- Currently residing in an Erickson Senior Living apartment home
- Sufficient English language skills to participate in study procedures
Exclusion
- Unable or unwilling to provide informed consent
- Unable or unwilling to participate in in-person group sessions
Key Trial Info
Start Date :
June 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 5 2023
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT05438134
Start Date
June 24 2022
End Date
April 5 2023
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114